Skip to content
Back to DMAC

DiaMedica Therapeutics Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
6
Purchases
6
Sales
0
Purchase value
$6.41M
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Stahlberg JAN10% owner
Trill AB10% owner
4
Filed Dec 8, 2025Period of report Nov 17, 20250001104659-25-119360
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 25, 2025
Common SharesF173,099$8.5749$626.82K8,825,742IndirectSee Footnote
PurchaseNov 24, 2025
Common SharesF140,253$7.8931$317.72K8,752,643IndirectSee Footnote
PurchaseNov 21, 2025
Common SharesF1208,872$7.4092$1.55M8,712,390IndirectSee Footnote
PurchaseNov 20, 2025
Common SharesF1128,426$7.4067$951.21K8,503,518IndirectSee Footnote
PurchaseNov 19, 2025
Common SharesF1240,352$7.2076$1.73M8,375,092IndirectSee Footnote
PurchaseNov 18, 2025
Common SharesF1182,882$6.7509$1.23M8,134,740IndirectSee Footnote
Filing footnotes · 1
  1. F1These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.